Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

This study is currently recruiting participants. (see Contacts and Locations)

Verified May 2017 by OHSU Knight Cancer Institute

Sponsor:

Collaborator:

National Cancer Institute (NCI)

Information provided by (Responsible Party):

Stephen Spurgeon, OHSU Knight Cancer Institute

ClinicalTrials.gov Identifier:

NCT01620216

First received: June 13, 2012

Last updated: May 18, 2017

Last verified: May 2017

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	September 2017
Estimated Primary Completion Date:	September 2017 (Final data collection date for primary outcome measure)